Research reading
Medicaments: containing alkaloids or their derivatives, containing ephedrine or its salts, for therapeutic or prophylactic uses, packaged for retail sale demand and the United States (USA) to Paraguay (PRY) lane
Paraguay (PRY) reported $561.6K of medicaments: containing alkaloids or their derivatives, containing ephedrine or its salts, for therapeutic or prophylactic uses, packaged for retail sale imports in 2021. United States (USA) accounted for 0.1% of the observed market and reported $272.0 in exports on this lane.
The latest annual values eased slightly, while the longer available history shows +7.2% buyer growth and -17.9% exporter growth. The page separates reported values from projections and indicators.
